Common questions

Can sulfonylureas be used with meglitinides?

Can sulfonylureas be used with meglitinides?

Although meglitinides can be used alone or together with other agents (e.g., metformin; Bailey, 2013), they should not be used with sulfonylureas because of their similar action (Kalra & Gupta, 2015; NIDDKD, 2015).

How does the meglitinides differ from the sulfonylureas?

The main difference between sulfonylureas and meglitinides is that meglitinides have a rapid onset of action as well as a short duration of activity. This makes meglitinides ideal for patients with postprandial hyperglycemia. Thus these drugs are taken just before meals to reduce postprandial hyperglycemia.

What is the therapeutic action of the sulfonylureas?

Sulfonylureas and meglitinides directly stimulate release of insulin from pancreatic beta cells and thereby lower blood glucose concentrations. Because they work by stimulating insulin secretion, they are useful only in patients with some beta cell function. Adverse effects may include weight gain and hypoglycemia.

Which of the following is a side effect of sulfonylureas?

Side effects of sulfonylureas may include:

  • Signs of low blood sugar, such as sweating, dizziness, confusion, or nervousness.
  • Hunger.
  • Weight gain.
  • Skin reactions.
  • Upset stomach.
  • Dark-colored urine.

How are meglitinides administered?

Meglitinides typically are prescribed to be taken about 15 minutes before meals three times a day. If you miss a meal, you should not take the drug.

Under what condition is meglitinides contraindicated?

The use of meglitinides is contraindicated in patients with type I diabetes or for the treatment of diabetic ketoacidosis, with or without coma.

How do sulfonylureas stimulate insulin?

Sulfonylureas are widely used to treat type 2 diabetes because they stimulate insulin secretion from pancreatic beta-cells. They primarily act by binding to the SUR subunit of the ATP-sensitive potassium (K(ATP)) channel and inducing channel closure.

Under what condition is Meglitinides contraindicated?

How does a sulfonylurea work?

How do sulphonylureas work? Sulphonylureas are insulin secretagogues, which means they work by causing the body to secrete insulin. Another class of diabetes drugs which works in this way is the prandial glucose regulators class.

What are the side effects of sulfonylureas and meglitinides?

Sulfonylureas and meglitinides directly stimulate release of insulin from pancreatic beta cells and thereby lower blood glucose concentrations. Because they work by stimulating insulin secretion, they are useful only in patients with some beta cell function. Adverse effects may include weight gain and hypoglycemia.

How does sulfonylureas work in the pancreas?

Sulfonylureas provoke a brisk release of insulin from pancreas. They act on the so called ‘sulfonylurea receptors’ (SUR1) on the pancreatic β cell membrane—cause depolarization by reducing conductance of ATP sensitive K+ channels. This enhances Ca2+ influx degranulation. The rate of insulin secretion at any glucose concentration is increased.

How does meglitinides work in the pancreas?

Meglitinides stimulate a shorter term burst of insulin to cover mealtimes. Common brands include: Where? Sulfonylureas and meglitinides work by stimulating the pancreas to release insulin.

What is the mechanism of action of sulfonylurea receptor?

Mechanism of action — The sulfonylurea receptor is a component of the adenosine triphosphate (ATP)-sensitive potassium channel (K-ATP channel) in the pancreatic beta cells [ 1 ]. The K-ATP channel regulates the release of insulin from pancreatic beta cells.

Author Image
Ruth Doyle